Company Filing History:
Years Active: 2002
Title: Petra Franzén: Innovator in Cancer Research
Introduction
Petra Franzén is a notable inventor based in Uppsala, Sweden. She has made significant contributions to the field of cancer research through her innovative work. Her research focuses on the development of nucleic acids and proteins that have potential applications in cancer treatment.
Latest Patents
Franzén holds a patent for PARG, a GTPase activating protein that interacts with PTPL1. The invention describes nucleic acids encoding the PARG protein, including fragments and biologically functional variants thereof. It also includes polypeptides and fragments encoded by such nucleic acids, along with antibodies related to these proteins. Additionally, methods and products for utilizing these nucleic acids and polypeptides are provided.
Career Highlights
Franzén is affiliated with the Ludwig Institute for Cancer Research Limited, where she continues her groundbreaking work. Her research has the potential to advance our understanding of cancer biology and improve therapeutic strategies.
Collaborations
Some of her notable coworkers include Jan Saras and Pontus Aspenström, who contribute to her research endeavors.
Conclusion
Petra Franzén's innovative work in cancer research exemplifies the impact of scientific inquiry on health and medicine. Her contributions through patents and collaborations highlight the importance of research in developing new therapeutic approaches.